CN104994889B - 用于改善疤痕组织的外观和形成的方法及组合物 - Google Patents

用于改善疤痕组织的外观和形成的方法及组合物 Download PDF

Info

Publication number
CN104994889B
CN104994889B CN201480009329.2A CN201480009329A CN104994889B CN 104994889 B CN104994889 B CN 104994889B CN 201480009329 A CN201480009329 A CN 201480009329A CN 104994889 B CN104994889 B CN 104994889B
Authority
CN
China
Prior art keywords
compositions
collagen
methods
wound
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480009329.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104994889A (zh
Inventor
K·卡泊恩
E·T·G·E·古恩
D·R·约翰逊
R·沃尔特斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Publication of CN104994889A publication Critical patent/CN104994889A/zh
Application granted granted Critical
Publication of CN104994889B publication Critical patent/CN104994889B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201480009329.2A 2013-02-19 2014-02-18 用于改善疤痕组织的外观和形成的方法及组合物 Expired - Fee Related CN104994889B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361766292P 2013-02-19 2013-02-19
US61/766,292 2013-02-19
US201361777059P 2013-03-12 2013-03-12
US61/777,059 2013-03-12
PCT/US2014/016834 WO2014130432A1 (en) 2013-02-19 2014-02-18 Methods and compositions for improving appearance and formation of scar tissue

Publications (2)

Publication Number Publication Date
CN104994889A CN104994889A (zh) 2015-10-21
CN104994889B true CN104994889B (zh) 2017-04-26

Family

ID=50239982

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480009329.2A Expired - Fee Related CN104994889B (zh) 2013-02-19 2014-02-18 用于改善疤痕组织的外观和形成的方法及组合物

Country Status (10)

Country Link
US (1) US9084740B2 (enExample)
EP (1) EP2958598B1 (enExample)
JP (1) JP6284956B2 (enExample)
CN (1) CN104994889B (enExample)
AU (1) AU2014219132B2 (enExample)
BR (1) BR112015019598B1 (enExample)
CA (1) CA2899424A1 (enExample)
MX (1) MX362459B (enExample)
RU (1) RU2673342C2 (enExample)
WO (1) WO2014130432A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10350153B2 (en) * 2017-03-31 2019-07-16 Johnson & Johnson Consumer Inc. Topical compositions comprising retinoids and low irritation polymeric cleansing agents
US20180280275A1 (en) * 2017-03-31 2018-10-04 Johnson & Johnson Consumer Inc. Methods of Improving the Activity of Retinoids
CN107213505A (zh) * 2017-07-27 2017-09-29 南京轩凯生物科技有限公司 一种抑制瘢痕形成的γ‑聚谷氨酸和透明质酸纤维伤口敷料及其制备方法
US12186335B2 (en) * 2020-04-23 2025-01-07 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
US12076414B2 (en) * 2020-04-23 2024-09-03 Johnson & Johnson Consumer Inc. Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers
US11690869B2 (en) 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
CN114099476B (zh) * 2021-11-22 2023-07-28 西安德诺海思医疗科技有限公司 一种功能性凝胶层、疤痕贴及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051326A1 (en) * 2001-12-14 2003-06-26 Medtrade Products Ltd. Cosmetic scar management composition
WO2005105115A1 (en) * 2004-05-04 2005-11-10 Queensland University Of Technology Functionalised siloxanes for scar tissue treatment
WO2010131032A2 (en) * 2009-05-11 2010-11-18 Pharmapatents Global Ltd Novel polymers

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4384096A (en) 1979-08-27 1983-05-17 The Dow Chemical Company Liquid emulsion polymers useful as pH responsive thickeners for aqueous systems
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4883864A (en) 1985-09-06 1989-11-28 Minnesota Mining And Manufacturing Company Modified collagen compound and method of preparation
CA1270996A (en) 1985-12-02 1990-06-26 Kien Van Phung Hydrophobe associative composition containing a polymer of water-soluble monomer and an amphiphilic monomer
US5179190A (en) 1988-10-28 1993-01-12 Regen Steven L Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
US4943624A (en) 1988-10-28 1990-07-24 Lehigh University Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
NL8900442A (nl) 1989-02-22 1990-09-17 Stichting Rega V Z W Gesulfateerde vinylpolymeren in geneesmiddelen voor het behandelen van retrovirus-infecties.
US5372807A (en) * 1990-05-14 1994-12-13 University Of Medicine And Dentistry Of New Jersey Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
CA2157691C (en) 1994-09-29 1998-08-18 Joseph Doolan High performance alkali-swellable rheological additives for aqueous systems
US5874495A (en) 1994-10-03 1999-02-23 Rhodia Inc. Polymers useful as PH responsive thickeners and monomers therefor
US5719194A (en) 1995-08-22 1998-02-17 Ausimont S.P.A. Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof
DE19626255C2 (de) 1996-06-29 1998-07-02 Juergen Prof Dr Hennig Verfahren der lokalisierten MR-Spektroskopie zur Messung überlappender Signale von gekoppelten Spinsystemen
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6060474A (en) * 1998-11-05 2000-05-09 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for preventing scar tissue formation
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6433061B1 (en) 2000-10-24 2002-08-13 Noveon Ip Holdings Corp. Rheology modifying copolymer composition
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7098180B2 (en) 2003-08-28 2006-08-29 Johnson & Johnson Consumer Companies Inc. Mild and effective cleansing compositions
US7157414B2 (en) 2003-08-28 2007-01-02 J&J Consumer Companies, Inc. Methods of reducing irritation in personal care compositions
US7084104B2 (en) 2003-08-28 2006-08-01 Johnson & Johnson Consumer Company Inc. Mild and effective cleansing compositions
WO2006108052A2 (en) 2005-04-06 2006-10-12 Genzyme Corporation Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
BRPI0608963B1 (pt) 2005-05-10 2016-02-23 Johnson & Johnson composição de baixa irritação e métodos para fabricação das mesmas
ES2389776T3 (es) 2005-05-31 2012-10-31 Rhodia, Inc. Composiciones que tienen modificadores reológicos HASE
US7803403B2 (en) 2006-11-09 2010-09-28 Johnson & Johnson Consumer Companies, Inc. Low-irritation compositions and methods of making the same
US20100008938A1 (en) 2007-01-22 2010-01-14 Anil Diwan Self assembling amphiphilic polymers as antiviral agents
US20100120907A1 (en) 2007-04-19 2010-05-13 Chandra Ulagaraj Singh Derivatives of amyris alcohols and eudesmol for treating cold sores and herpes
US20110054375A1 (en) * 2007-11-27 2011-03-03 Hans Smola Dressing comprising polyacrylate particles and use thereof
DE102008021360A1 (de) 2008-04-29 2009-11-05 Siemens Aktiengesellschaft Verfahren und Vorrichtung zum Erkennen eines Lagerschadens
US8258250B2 (en) 2009-10-07 2012-09-04 Johnson & Johnson Consumer Companies, Inc. Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof
WO2011107440A1 (en) 2010-03-02 2011-09-09 Basf Se Anionic associative rheology modifiers
US8343902B2 (en) 2010-06-24 2013-01-01 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8329627B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8329626B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
SI2563374T1 (sl) 2010-07-08 2014-01-31 Devirex Ag Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra
US8778864B2 (en) 2010-11-15 2014-07-15 Johnson & Johnson Consumer Companies, Inc. Polyglyceryl compounds and compositions
US8338348B2 (en) 2010-12-21 2012-12-25 Johnson & Johnson Consumer Companies, Inc. Skin cleansing compositions with polyglycerol esters and hydrophobically modified polymers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051326A1 (en) * 2001-12-14 2003-06-26 Medtrade Products Ltd. Cosmetic scar management composition
WO2005105115A1 (en) * 2004-05-04 2005-11-10 Queensland University Of Technology Functionalised siloxanes for scar tissue treatment
WO2010131032A2 (en) * 2009-05-11 2010-11-18 Pharmapatents Global Ltd Novel polymers

Also Published As

Publication number Publication date
EP2958598A1 (en) 2015-12-30
BR112015019598B1 (pt) 2020-06-23
CN104994889A (zh) 2015-10-21
US20140234249A1 (en) 2014-08-21
JP6284956B2 (ja) 2018-02-28
AU2014219132B2 (en) 2017-10-19
EP2958598B1 (en) 2018-11-21
US9084740B2 (en) 2015-07-21
HK1217453A1 (en) 2017-01-13
RU2015139585A (ru) 2017-03-23
CA2899424A1 (en) 2014-08-28
MX2015010650A (es) 2016-06-06
MX362459B (es) 2019-01-18
WO2014130432A1 (en) 2014-08-28
RU2673342C2 (ru) 2018-11-26
JP2016509026A (ja) 2016-03-24
RU2015139585A3 (enExample) 2018-03-01
AU2014219132A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
CN104994889B (zh) 用于改善疤痕组织的外观和形成的方法及组合物
JP2001520180A (ja) 少なくとも１種のポリヒドロキシル化有機化合物と組み合わされた本質的に非晶質のセルロースナノフィブリルの、化粧品調合物中における使用
KR20150128481A (ko) 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물
EP3055031A1 (fr) Utilisation en cosmetique de polymeres obtenus par polymerisation en emulsion inverse basse concentration avec un faible taux de monomeres neutralises
EP2958634B1 (en) Methods and compositions for improving appearance and formation of scar tissue
KR102733161B1 (ko) 레티노이드 및 저자극 중합체 클렌징제를 포함하는 국소 조성물
HK1217453B (en) Methods and compositions for improving appearance and formation of scar tissue
CN108685753B (zh) 改善类视色素的活性的方法
EP4267244A1 (en) Formulation comprising erbium borate for use in prevention and treatment of wound scars
EP4391988A1 (en) Mask for caring for keratin materials
CN117045844A (zh) 一种含多聚糖的敷料及其制备方法和应用
CN120713787A (zh) 一种超分子水凝胶组合物及其制备方法和应用
FR2959415A1 (fr) Composition dermatologique a base d'huile d'argan et d'acide hyaluronique.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170426

Termination date: 20210218

CF01 Termination of patent right due to non-payment of annual fee